Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Mologen AG logo — Crafting Hope and Healing for Cancer and Infectious Diseases...

Mologen AG

Crafting Hope and Healing for Cancer and Infectious Diseases Since 1998

Founded 1998 Biopharma, Pharmaceutical

General Information

Company Name Mologen AG
Founded Year 1998
Industries Biopharma, Pharmaceutical
Social

Get notified when Mologen AG moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Mologen AG

Mologen AG is a biopharma and pharmaceutical startup that has been crafting hope and healing for cancer and infectious diseases since 1998. Headquartered in Berlin, the company was established by Prof. Burghardt Wittig and currently employs approximately 50 professionals. Specializing in the research and clinical development of innovative drugs targeting cancer and infectious diseases, Mologen operates on an international scale. Despite lacking specific details on the last investment, the company presents an intriguing opportunity for venture capital investors in the biopharma and pharmaceutical industries.

Taxonomy: Biopharmaceutical, Research and Development, Innovative Drugs, Cancer Treatment, Infectious Diseases, Clinical Development, International Operations, Berlin-based, Prof. Burghardt Wittig, Drug Research, Cancer Research, Biotech Industry, Healthcare Innovation, Medical Research, Pharmaceutical Company

No funding data available for Mologen AG yet.

Get notified when Mologen AG raises funding

Mologen AG Alternatives & Competitors

Mologen AG vs
PROVECTUS PHARMACEUTICALS
PROVECTUS PHARMACEUTICALS

Developing advanced therapies to target and destroy the deadliest cancers – melanoma, liver, and bre...

Post Ipo Equity
Biotechnology, Pharmaceutical
Mologen AG vs
San Antonio Breast Cancer Symposium
San Antonio Breast Cancer Symposium United States

An international symposium fostering interaction and exchange among leaders in breast cancer researc...

3 employees
Health Care
Mologen AG vs
Pediatric Cancer Research Foundation
Pediatric Cancer Research Foundation United States

A nonprofit committed to funding breakthrough research and accelerating new cures for pediatric canc...

23 employees
Government and Military

FAQ About Mologen AG

Crafting Hope and Healing for Cancer and Infectious Diseases Since 1998
Mologen AG was founded in 1998.
Mologen AG operates in the following industries: Biopharma, Pharmaceutical.
Top alternatives and competitors to Mologen AG include PROVECTUS PHARMACEUTICALS, San Antonio Breast Cancer Symposium, Pediatric Cancer Research Foundation, Rutgers Cancer Institute, Ohana Vaccines, LLC. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Mologen AG and PROVECTUS PHARMACEUTICALS are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Mologen AG and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy